Efficacy and safety of tirzepatide, dual GLP-1/GIP receptor agonists, in the management of type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials.

Qian ZhouXingxing LeiShunlian FuPan LiuCong LongYanmei WangZinan LiQian XieQiu Chen

Published in: Diabetology & metabolic syndrome (2023)

The Tirzepatide, a dual GIP/GLP-1 receptor co-agonist, for diabetes therapy has opened a new era on personalized glycemia control and weight loss in a safe manner with broad and promising clinical implications.

Keyphrases

weight loss
type diabetes
bariatric surgery
systematic review
cardiovascular disease
glycemic control
roux en y gastric bypass
stem cells
physical activity
adipose tissue
metabolic syndrome
binding protein
skeletal muscle
body mass index
replacement therapy
obese patients